Hundreds of people braved the chilly rain on Saturday morning to take part in the Georgia Brain Tumor Walk and Race to raise ...

Michael Bolton has opened up about the ways he relied on his family at his Connecticut residence during his aggressive brain ...

That July, Charlotte was hospitalized after waking up with a debilitating migraine. She never returned home. On July 9, ...

Mike Hazen had just hung up the phone, having spoken with me about the Diamondbacks’ upcoming “Brain Tumor Awareness Night,” ...

Michael Bolton, the celebrated singer, is battling glioblastoma, an aggressive brain cancer, after being diagnosed in ...

The phase 2B SURVIVE trial testing SurVaxM, a cancer vaccine for glioblastoma, will continue as planned following an interim analysis showing sufficient promise to proceed.

Researchers detail their discoveries about why the brain tumor glioblastoma is so aggressive. Their findings center on ZIP4, a protein that transports zinc throughout the body and sets off a cascade ...

Michael Bolton, the celebrated singer, is battling glioblastoma, an aggressive brain cancer, after being diagnosed in December 2023. Following multiple surgeries, radiation, and chemotherapy ...

May 1, 2025 — Researchers detail their discoveries about why the brain tumor glioblastoma is so aggressive. Their findings center on ZIP4, a protein that transports zinc throughout the body and ...

Having a larger brain tumor at diagnosis is associated with a higher risk of death, longer hospital stays, and greater neurological deficits, a study suggests.

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system more effectively than traditional therapies, particularly against evasive and ...

Glioblastoma (GBM) is the most common and lethal brain malignancy in adults, with fewer than 5% of patients surviving five ...